Business Description
Merit Medical Systems Inc
NAICS : 339112
SIC : 3841
ISIN : US5898891040
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.66 | |||||
Equity-to-Asset | 0.52 | |||||
Debt-to-Equity | 0.74 | |||||
Debt-to-EBITDA | 3.89 | |||||
Interest Coverage | 8.12 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 3.82 | |||||
Beneish M-Score | -2.84 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 7.4 | |||||
3-Year EBITDA Growth Rate | 28 | |||||
3-Year EPS without NRI Growth Rate | 53.7 | |||||
3-Year FCF Growth Rate | -3.9 | |||||
3-Year Book Growth Rate | 6.4 | |||||
Future 3-5Y EPS without NRI Growth Rate | 10.83 | |||||
Future 3-5Y Total Revenue Growth Rate | 5.4 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 60.36 | |||||
9-Day RSI | 55.6 | |||||
14-Day RSI | 52.1 | |||||
6-1 Month Momentum % | 14.84 | |||||
12-1 Month Momentum % | -6.13 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.45 | |||||
Quick Ratio | 3.95 | |||||
Cash Ratio | 2.88 | |||||
Days Inventory | 159.26 | |||||
Days Sales Outstanding | 49.44 | |||||
Days Payable | 33.67 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.3 | |||||
Shareholder Yield % | -4.59 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 46.44 | |||||
Operating Margin % | 10.01 | |||||
Net Margin % | 7.51 | |||||
FCF Margin % | 8.63 | |||||
ROE % | 7.93 | |||||
ROA % | 5.07 | |||||
ROIC % | 7.02 | |||||
ROC (Joel Greenblatt) % | 16.93 | |||||
ROCE % | 7.68 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 45.26 | |||||
Forward PE Ratio | 22.27 | |||||
PE Ratio without NRI | 30.74 | |||||
Shiller PE Ratio | 98.95 | |||||
Price-to-Owner-Earnings | 50.64 | |||||
PEG Ratio | 2.54 | |||||
PS Ratio | 3.42 | |||||
PB Ratio | 3.55 | |||||
Price-to-Tangible-Book | 8.64 | |||||
Price-to-Free-Cash-Flow | 39.71 | |||||
Price-to-Operating-Cash-Flow | 29.67 | |||||
EV-to-EBIT | 35.96 | |||||
EV-to-EBITDA | 20.05 | |||||
EV-to-Forward-EBITDA | 16.58 | |||||
EV-to-Revenue | 3.65 | |||||
EV-to-Forward-Revenue | 3.48 | |||||
EV-to-FCF | 42.31 | |||||
Price-to-Projected-FCF | 2.4 | |||||
Price-to-DCF (Earnings Based) | 1.69 | |||||
Price-to-DCF (FCF Based) | 3.44 | |||||
Price-to-Median-PS-Value | 1.19 | |||||
Price-to-Peter-Lynch-Fair-Value | 2.4 | |||||
Price-to-Graham-Number | 3.44 | |||||
Earnings Yield (Greenblatt) % | 2.78 | |||||
FCF Yield % | 2.53 | |||||
Forward Rate of Return (Yacktman) % | 14.65 |